Hisun Pharmaceutical
Hisun Pharmaceutical, officially known as Zhejiang Hisun Pharmaceutical Co., Ltd., is a prominent player in the global pharmaceutical industry, headquartered in CN. Founded in 1956, the company has established a strong presence in major operational regions, including Asia, Europe, and North America. Hisun Pharmaceutical focuses on the research, development, and manufacturing of a diverse range of products, including generic drugs, active pharmaceutical ingredients (APIs), and innovative therapies. With a commitment to quality and innovation, Hisun has achieved significant milestones, including numerous certifications and partnerships that enhance its market position. The company is recognised for its unique approach to drug development, particularly in oncology and cardiovascular treatments. Hisun Pharmaceutical continues to make strides in the industry, solidifying its reputation as a trusted provider of high-quality pharmaceutical solutions.
DitchCarbon Score
How does Hisun Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hisun Pharmaceutical's score of 0 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Hisun Pharmaceutical's reported carbon emissions
Hisun Pharmaceutical, headquartered in China (CN), currently does not have publicly available carbon emissions data for the most recent year, nor does it specify any reduction targets or climate commitments. Without specific emissions figures or reduction initiatives, it is challenging to assess the company's climate impact or sustainability efforts. However, the pharmaceutical industry is increasingly focusing on reducing carbon footprints and enhancing sustainability practices. As such, Hisun Pharmaceutical may be expected to align with industry trends towards greater transparency and commitment to climate action in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hisun Pharmaceutical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
